Virgilio Deloy Capobian Gibbon Sells 770 Shares of Afya (NASDAQ:AFYA) Stock

Afya Limited (NASDAQ:AFYA) CEO Virgilio Deloy Capobian Gibbon sold 770 shares of the stock in a transaction that occurred on Monday, April 6th. The stock was sold at an average price of $14.91, for a total value of $11,480.70. Following the completion of the sale, the chief executive officer owned 108,448 shares in the company, valued at approximately $1,616,959.68. The trade was a 0.71% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Virgilio Deloy Capobian Gibbon also recently made the following trade(s):

• On Thursday, April 2nd, Virgilio Deloy Capobian Gibbon sold 20,900 shares of Afya stock. The stock was sold at an average price of $14.94, for a total value of $312,246.00.
• On Wednesday, April 1st, Virgilio Deloy Capobian Gibbon sold 19,500 shares of Afya stock. The stock was sold at an average price of $14.98, for a total value of $292,110.00.
• On Tuesday, March 31st, Virgilio Deloy Capobian Gibbon sold 2,320 shares of Afya stock. The stock was sold at an average price of $14.92, for a total transaction of $34,614.40.
• On Thursday, March 26th, Virgilio Deloy Capobian Gibbon sold 800 shares of Afya stock. The stock was sold at an average price of $15.21, for a total transaction of $12,168.00.
• On Wednesday, March 25th, Virgilio Deloy Capobian Gibbon sold 3,900 shares of Afya stock. The stock was sold at an average price of $15.18, for a total transaction of $59,202.00.

Afya Trading Up 0.2%

AFYA stock traded up $0.03 during trading on Monday, hitting $14.99. The company had a trading volume of 197,630 shares, compared to its average volume of 113,194. The firm has a market capitalization of $1.40 billion, a P/E ratio of 10.27, a PEG ratio of 0.67 and a beta of 0.48. Afya Limited has a 52-week low of $13.00 and a 52-week high of $19.90. The company has a 50 day simple moving average of $14.48 and a 200-day simple moving average of $14.70. The company has a quick ratio of 0.98, a current ratio of 2.20 and a debt-to-equity ratio of 0.21.

Afya (NASDAQ:AFYA) last posted its earnings results on Wednesday, March 11th. The company reported $0.41 EPS for the quarter, beating analysts’ consensus estimates of $0.36 by $0.05. The business had revenue of $147.08 million for the quarter, compared to the consensus estimate of $174.74 million. Afya had a net margin of 20.31% and a return on equity of 18.77%. As a group, research analysts forecast that Afya Limited will post 1.52 earnings per share for the current fiscal year.

Afya Dividend Announcement

The firm also recently announced an annual dividend, which will be paid on Monday, April 6th. Shareholders of record on Wednesday, March 25th will be given a dividend of $0.656 per share. The ex-dividend date of this dividend is Wednesday, March 25th. This represents a yield of 433.0%. Afya’s dividend payout ratio (DPR) is 45.21%.

Institutional Trading of Afya

Institutional investors have recently bought and sold shares of the stock. Daiwa Securities Group Inc. acquired a new stake in Afya in the 4th quarter worth approximately $43,000. Militia Capital Partners LP acquired a new stake in Afya in the 2nd quarter worth approximately $71,000. Quantbot Technologies LP acquired a new stake in Afya during the 2nd quarter valued at approximately $117,000. State of Wyoming acquired a new stake in Afya during the 2nd quarter valued at approximately $164,000. Finally, Van ECK Associates Corp lifted its stake in Afya by 15.7% during the 3rd quarter. Van ECK Associates Corp now owns 10,170 shares of the company’s stock valued at $159,000 after acquiring an additional 1,377 shares during the period. 88.02% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts have commented on AFYA shares. Zacks Research raised shares of Afya from a “strong sell” rating to a “hold” rating in a research report on Monday, March 9th. Bank of America downgraded shares of Afya from a “buy” rating to a “neutral” rating and cut their target price for the company from $22.00 to $17.00 in a research report on Tuesday, February 24th. UBS Group reissued a “neutral” rating and set a $16.00 target price (down from $18.00) on shares of Afya in a research report on Friday, January 16th. Weiss Ratings reissued a “hold (c)” rating on shares of Afya in a research report on Wednesday, January 21st. Finally, JPMorgan Chase & Co. reissued a “neutral” rating and set a $22.00 target price (down from $24.50) on shares of Afya in a research report on Wednesday, January 7th. One investment analyst has rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $17.30.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.